Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 2/20 | 0.51 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.51 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | F9 | P00740 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25155380 | 1.00 | CACNA1H (0.51) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CACNA1G | |
| SCHEMBL25155393 | 0.90 | CACNA1H (0.50) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CACNA1G | |
| SCHEMBL31360280 | 0.90 | CACNA1H (0.50) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CACNA1G | |
| SCHEMBL29615656 | 0.83 | CACNA1H (0.52) | CACNA1HCACNA1BCACNA1CSMN1; SMN2TSHR | |
| SCHEMBL24507620 | 0.83 | CACNA1H (0.52) | CACNA1HCACNA1BCACNA1CSMN1; SMN2TSHR | |
| SCHEMBL23522706 | 0.81 | CACNA1G (0.62) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CACNA1G | |
| SCHEMBL30313258 | 0.80 | CACNA1H (0.54) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CACNA1G | |
| SCHEMBL19494569 | 0.80 | SMN1; SMN2 (0.62) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CYP1A2 | |
| SCHEMBL25155252 | 0.79 | SMN1; SMN2 (0.44) | CACNA1HCACNA1BCACNA1CSMN1; SMN2CYP1A2 | |
| SCHEMBL31359907 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | Clear Creek Bio, Inc. (US) | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | ACE, PREP, PEPD | CACNA1H 1528/4885CACNA1B 1177/4885CACNA1C 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.